The evolutionary history of the polyQ tract in huntingtin sheds light on its functional pro-neural activities.
Raffaele IennacoGiulio FormentiCamilla TrovesiRiccardo Lorenzo RossiChiara ZuccatoTiziana LischettiVittoria Dickinson BocchiAndrea ScolzCristina Martínez-LabargaOlga RickardsMichela PacificoAngelica CrottiniAnders Pape MøllerRichard Zhenghuan ChenThomas Francis VogtGiulio PavesiDavid Stephen HornerNicola SainoElena CattaneoPublished in: Cell death and differentiation (2022)
Huntington's disease is caused by a pathologically long (>35) CAG repeat located in the first exon of the Huntingtin gene (HTT). While pathologically expanded CAG repeats are the focus of extensive investigations, non-pathogenic CAG tracts in protein-coding genes are less well characterized. Here, we investigated the function and evolution of the physiological CAG tract in the HTT gene. We show that the poly-glutamine (polyQ) tract encoded by CAGs in the huntingtin protein (HTT) is under purifying selection and subjected to stronger selective pressures than CAG-encoded polyQ tracts in other proteins. For natural selection to operate, the polyQ must perform a function. By combining genome-edited mouse embryonic stem cells and cell assays, we show that small variations in HTT polyQ lengths significantly correlate with cells' neurogenic potential and with changes in the gene transcription network governing neuronal function. We conclude that during evolution natural selection promotes the conservation and purity of the CAG-encoded polyQ tract and that small increases in its physiological length influence neural functions of HTT. We propose that these changes in HTT polyQ length contribute to evolutionary fitness including potentially to the development of a more complex nervous system.
Keyphrases
- genome wide
- genome wide identification
- copy number
- dna methylation
- embryonic stem cells
- spinal cord injury
- induced apoptosis
- physical activity
- transcription factor
- crispr cas
- single cell
- stem cells
- body composition
- genome wide analysis
- high throughput
- cell therapy
- mass spectrometry
- cell cycle arrest
- cell death
- mesenchymal stem cells
- risk assessment
- protein protein
- binding protein
- blood brain barrier
- atomic force microscopy
- cerebral ischemia